...
首页> 外文期刊>Journal of immunotherapy >Comprehensive method for the typing of HLA-A, B, and C alleles by direct sequencing of PCR products obtained from genomic DNA.
【24h】

Comprehensive method for the typing of HLA-A, B, and C alleles by direct sequencing of PCR products obtained from genomic DNA.

机译:通过直接测序从基因组DNA获得的PCR产物,对HLA-A,B和C等位基因进行分型的综合方法。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Molecular testing is gradually replacing standard typing techniques in the field of HLA because it allows higher resolution, which has significant functional implications. Although several techniques have been so far described for this purpose, the definitive means to determine which alleles are present in a particular sample is to identify their sequence. We describe a simplified method for typing HLA-A, B, and C alleles by direct sequencing of polymerase chain reaction (PCR) products amplified from genomic DNA that could allow large-scale handling of samples for clinical use. The template is the product of a nested PCR. A first round of PCR amplifications from genomic DNA is performed with three different sets of primers, one pair specific for each locus. The PCR products encompass exons 2 and 3, the regions of interest to determine the allele present. These fragments are a mixture of both alleles present in one locus. In a second round of PCRs using the first fragment as template, exons 2 and 3 are separately amplified and simultaneously tailed with sequences corresponding to fluorescent-labeled commercial primers. The sense and antisense sequence of each exon is obtained and compared with a database of all known HLA-A, B, or C alleles. Heterozygous positions are determined and the most probable alleles assigned. This simplified procedure has the practical advantage of allowing high-resolution typing of clinical material by utilizing the same genomic DNA used for standard molecular typing of HLA class I.
机译:分子测试正在逐步取代HLA领域中的标准打字技术,因为它可以实现更高的分辨率,这对功能具有重要意义。尽管到目前为止已经为此目的描述了几种技术,但是确定特定样品中存在哪些等位基因的确定手段是鉴定其序列。我们描述了一种简单的方法,用于通过从基因组DNA扩增的聚合酶链反应(PCR)产品进行直接测序来对HLA-A,B和C等位基因进行分型,从而可以大规模处理临床样品。模板是嵌套式PCR的产物。用三组不同的引物对基因组DNA进行第一轮PCR扩增,每个引物一对。 PCR产物包含外显子2和3,这是确定存在等位基因的目标区域。这些片段是一个基因座中两个等位基因的混合物。在使用第一片段作为模板的第二轮PCR中,分别扩增外显子2和3,并同时尾随对应于荧光标记的商业引物的序列。获得每个外显子的有义和反义序列,并将其与所有已知的HLA-A,B或C等位基因的数据库进行比较。确定杂合子位置并分配最可能的等位基因。这种简化的程序具有实际优势,可以通过利用与用于HLA I类标准分子分型的基因组DNA相同的基因组DNA进行高分辨率分型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号